Advertisement

Drug Safety

, Volume 9, Issue 2, pp 93–103 | Cite as

Benzodiazepine Dependence

Avoidance and Withdrawal
  • Sarah Marriott
  • Peter Tyrer
Commentary

Summary

Benzodiazepine dependence is a frequent complication of regular prescriptions for 4 weeks or longer, occurring in almost one-third of patients. Although it is also manifested by tolerance to drug effects and occasional drug seeking behaviour, particularly in those prone to drug abuse, most dependence is characterised by a withdrawal syndrome on stopping treatment. The withdrawal syndrome includes symptoms of anxiety and those of perceptual disturbance such as depersonalisation, hypersensitivity of all major senses, dysphoria and (rarely) epileptic seizures and psychotic episodes. Risk factors for dependence include high dosage, use of more potent and short acting benzodiazepines, long duration of therapy and dependent premorbid personality characteristics. If none of these apply, benzodiazepines can be prescribed with safety.

Keywords

Personality Disorder Withdrawal Symptom Panic Disorder Buspirone Withdrawal Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ashton CH, Rawlins MD, Tyrer SP. A double-blind placebo-controlled study of buspirone in diazepam withdrawal in chronic benzodiazepine users. British Journal of Psychiatry 157: 232–238, 1990PubMedCrossRefGoogle Scholar
  2. Ashton H. Benzodiazepine withdrawal: outcome in 50 patients. British Journal of Addiction 82: 665–671, 1987PubMedCrossRefGoogle Scholar
  3. Barnes GE. The alcoholic personality: a review of the literature. Journal of Studies on Alcohol 40: 571–634, 1979PubMedGoogle Scholar
  4. Beaumont G. The use of benzodiazepines in general practice. In Hindmarch et al. (Eds) Benzodiazepines: current concepts, pp. 141–152, John Wiley & Sons, Chichester, 1990Google Scholar
  5. Brandon S. Clinical use of benzodiazepines in anxiety and panic disorders. In Hindmarch et al. (Eds) Benzodiazepines: current concepts, pp. 111–139, John Wiley & Sons, Chichester, 1990Google Scholar
  6. Busto U, Sellers E, Naranjo CA, Cappell H, Sanchez-Craig M, et al. Withdrawal reaction after long-term therapeutic use of benzodiazepines. New England Journal of Medicine 315: 854–859, 1986PubMedCrossRefGoogle Scholar
  7. Butler G, Cullington A, Hibbert G, Klines I, Gelder M. Anxiety management for persistent generalised anxiety. British Journal of Psychiatry 151: 535–542, 1987PubMedCrossRefGoogle Scholar
  8. Cormack MA, Owens RG, Dewey ME. The effect of minimal interventions by general practitioners on long-term benzodiazepine use. Journal of the Royal College of General Practitioners 39: 408–411, 1989PubMedGoogle Scholar
  9. Cowen PJ, Nutt DJ. Abstinence symptoms after withdrawal of tranquilising drugs: is there a common neurochemical mechanism? Lancet 2: 360–362, 1982PubMedCrossRefGoogle Scholar
  10. Fontaine R, Chouinard G, Annable L. Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment. American Journal of Psychiatry 141: 845–852, 1984Google Scholar
  11. Greenblatt DJ, Shader RI, Divoll M, Harmatz BA. Benzodiazepines: a summary of pharmacokinetic properties. British Journal of Clinical Pharmacology 11: 115–165, 1981CrossRefGoogle Scholar
  12. Holton A, Riley P, Tyrer P. Factors predicting long-term outcome after chronic benzodiazepine therapy. Journal of Affective Disorders 24: 245–252, 1992PubMedCrossRefGoogle Scholar
  13. King MB, Gabe J, Williams P, Rodrigo EK. Long-term use of benzodiazepines: the views of patients. British Journal of General Practice 40: 194–196, 1990PubMedGoogle Scholar
  14. Lader M. History of benzodiazepine dependence. Journal of Substance Abuse Treatment 8: 53–59, 1991PubMedCrossRefGoogle Scholar
  15. Lader M, Beaumont G, Bond A, Butler G, Cobb J, et al. Guidelines for the management of patients with generalised anxiety. Psychiatric Bulletin 16: 560–565, 1992CrossRefGoogle Scholar
  16. Little HJ, Nutt DJ, Taylor SC. Bi-directional effects of chronic treatment with agonists and inverse agonists at the benzodiazepine receptor complex. Brain Research Reviews 19: 371, 1987Google Scholar
  17. Marks J. The benzodiazepines: use, overuse, misuse, abuse, MTP Press, Lancaster, 1978Google Scholar
  18. Miller NS, Gold MS. Benzodiazepines: a major problem. Introduction. Journal of Substance Abuse Treatment 8: 3–7, 1991PubMedCrossRefGoogle Scholar
  19. Munby M, Johnstone DW. Agoraphobia: the long-term followup of behavioural treatment. British Journal of Psychiatry 137: 418–427, 1980PubMedCrossRefGoogle Scholar
  20. Murphy SM, Owen RT, Tyrer PJ. Withdrawal symptoms after six weeks treatment with diazepam. Lancet 1: 1389, 1984CrossRefGoogle Scholar
  21. Murphy SM, Tyrer P. The essence of benzodiazepine dependence. In Lader (Ed.) The psychopharmacology of addiction, pp. 157–167, Oxford University Press, London, 1988Google Scholar
  22. Murphy SM, Tyrer P. A double-blind comparison of the effects of gradual withdrawal of lorazepam, diazepam and bromazepam in benzodiazepine dependence. British Journal of Psychiatry 158: 511–516, 1991PubMedCrossRefGoogle Scholar
  23. Nutt DJ. Benzodiazepine dependence: New insights into basic research. In Hindmarch et al. (Eds) Benzodiazepines: current concepts, pp. 19–41, John Wiley & Sons, Chichester, 1990Google Scholar
  24. Onyett SR. The benzodiazepine withdrawal syndrome and its management. Journal of the Royal College of General Practioners, 39: 160–163, 1989Google Scholar
  25. Petursson H, Lader MH. Withdrawal from long-term benzodiazepine treatment. British Medical Journal 283: 643–645, 1981PubMedCrossRefGoogle Scholar
  26. Power KG, Jerrom DWA, Simpson RJ, Mitchell M. Controlled study of withdrawal symptoms and rebound anxiety after six weeks course of diazepam for generalised anxiety. British Medical Journal 290: 1246–1248, 1985PubMedCrossRefGoogle Scholar
  27. Priest RG, Montgomery SA. Benzodiazepines and dependence: a College statement. Bulletin of the Royal College of Psychiatrists 12: 107–109, 1988CrossRefGoogle Scholar
  28. Rickels K, Case WG, Schweizer E, Garcia-Espana F, Fridman R. Benzodiazepine dependence: management of discontinuation. Psychopharmocology Bulletin 26: 63–68, 1989Google Scholar
  29. Schweizer E, Clary C, Dever AI, Mandos LA. The use of low dose midazolam to treat panic disorder: a pilot study. Journal of Clinical Psychiatry 53: 19–22, 1992PubMedGoogle Scholar
  30. Seivewright N, Dougal W. Withdrawal symptoms from high dose benzodiazepines in polydrug users. Drug and Alcohol Dependence 32: 15–23, 1993PubMedCrossRefGoogle Scholar
  31. Tesar GE. High potency benzodiazepine for short-term treatment of panic disorder: the US experience. Journal of Clinical Psychiatry 51: 4–10, 1990PubMedGoogle Scholar
  32. Tyrer P. Dependence on benzodiazepines. British Journal of Psychiatry 137: 576–577, 1980PubMedCrossRefGoogle Scholar
  33. Tyrer P. Neurosis divisible?. Lancet 1: 685–688, 1985PubMedCrossRefGoogle Scholar
  34. Tyrer P. How to stop taking tranquillisers, Sheldon Press, London, 1986Google Scholar
  35. Tyrer P. Dependence as a limiting factor in the clinical use of minor tranquillizers. Pharmacology and Therapeutics 36: 173–188, 1988PubMedCrossRefGoogle Scholar
  36. Tyrer P. Current problems with the benzodiazepines. In Wheatley (Ed.) The anxiolytic jungle: where next?, pp. 23–36, John Wiley, Chichester, 1990Google Scholar
  37. Tyrer P. The nocebo effect: poorly known but getting stronger. In Dukes & Aronson (Eds) Side effects of drugs annual 15, pp. xix–xxv, Elsevier, Amsterdam, 1991aGoogle Scholar
  38. Tyrer P. Qui devient dependant des benzodiazepines? In Venisse JL (Ed.) Les nouvelles addictions, pp. 142–147, Masson, Paris, 1991bGoogle Scholar
  39. Tyrer P. Pharmacological differences between benzodiazepines. In Hallstrom (Ed.) Benzodiazepine dependence, Oxford University Press, London, 1993aGoogle Scholar
  40. Tyrer P. Withdrawal from hypnotic drugs. British Medical Journal 305: 706–708, 1993bCrossRefGoogle Scholar
  41. Tyrer P, Owen R, Dawling S. Gradual withdrawal of diazepam after long-term therapy. Lancet 1: 1402–1406, 1983PubMedCrossRefGoogle Scholar
  42. Tyrer P, Murphy S, Oates G, Kingdon D. Psychological treatment for benzodiazepine dependence. Lancet 1: 1042–1043, 1986Google Scholar
  43. Tyrer P, Murphy S, Riley P. The Benzodiazepine Withdrawal Symptom Questionnaire. Journal of Affective Disorders 19: 53–61, 1990PubMedCrossRefGoogle Scholar
  44. Tyrer P, Rutherford D, Huggett T. Benzodiazepine withdrawal symptoms and propranolol. Lancet 1: 520–522, 1981PubMedCrossRefGoogle Scholar
  45. Tyrer P, Sievewright N. Identification and management of benzodiazepine dependence. Postgraduate Medical Journal 60: 41–46, 1984PubMedGoogle Scholar
  46. Tyrer P, Seivewright N, Ferguson B, Tyrer J. The general neurotic syndrome: a coaxial diagnosis of anxiety, depression and personality disorder. Acta Psychiatrica Scandinavica 85: 201–206, 1992PubMedCrossRefGoogle Scholar
  47. Winokur A, Rickels K, Greenblatt PJ, Snyder PJ, Schatz NJ. Withdrawal reaction from long-term low dosage administration of diazepam. Archives of General Psychiatry 37: 101–105, 1980PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 1993

Authors and Affiliations

  • Sarah Marriott
    • 1
  • Peter Tyrer
    • 1
  1. 1.Department of Community PsychiatrySt Charles’ HospitalLondonEngland

Personalised recommendations